Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Protection of Differentiating Neuronal Cells from Amyloid β Peptide-induced Injury by Alkaline Extract of Leaves of Sasa senanensis Rehder

HIROSHI SAKAGAMI, MAYUMI TSUJI, MINEKO TOMOMURA, YOSHIKO MASUDA, SOICHI IWAMA, MIKA NAKAGAWA, HAYATO SUZUKI, KENTA TANAKA, TOMOYUKI ABE, NOBUAKI TAMURA, AKITO TOMOMURA, SATOSHI YOKOSE, HIROSHI TAKESHIMA, TAKENORI NATORI, MISAKI HORIUCHI, TOMOHIRO FUJISAWA, YUJI KIUCHI, KATSUJI OGUCHI, TOSHIKAZU YASUI, HIROSHI OIZUMI and TAKAAKI OIZUMI
In Vivo March 2018, 32 (2) 231-239;
HIROSHI SAKAGAMI
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sakagami@dent.meikai.ac.jp
MAYUMI TSUJI
2School of Medicine, Showa University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MINEKO TOMOMURA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIKO MASUDA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOICHI IWAMA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIKA NAKAGAWA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAYATO SUZUKI
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTA TANAKA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOYUKI ABE
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBUAKI TAMURA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKITO TOMOMURA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SATOSHI YOKOSE
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI TAKESHIMA
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKENORI NATORI
3Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MISAKI HORIUCHI
4Daiwa Biological Research Institute Co., Ltd., Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIRO FUJISAWA
4Daiwa Biological Research Institute Co., Ltd., Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJI KIUCHI
2School of Medicine, Showa University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUJI OGUCHI
2School of Medicine, Showa University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIKAZU YASUI
1Meikai University School of Dentistry, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI OIZUMI
4Daiwa Biological Research Institute Co., Ltd., Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAAKI OIZUMI
4Daiwa Biological Research Institute Co., Ltd., Kanagawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: We have previously reported the protection of doxorubicin-induced keratinocyte toxicity by alkaline extract of the leaves of Sasa senanensis Rehder (SE). In order to extend the generality of the cell protective effect of SE, we investigated whether it also protects rat PC12 and human SH-SY5Y neuron model cells from amyloid β-peptide (Aβ)-induced injury. Materials and Methods: Viability of cells was determined by the MTT method. Cytotoxicity was evaluated by the concentration that reduces the cell viability by 50% (CC50). Protection from Aβ-induced cytotoxicity was evaluated by the concentration that reversed the Aβ-induced reduction of viability by 50% (EC50). The selectivity index (SI) of neuroprotective activity was defined as the ratio of EC50 to CC50. Aβ1-42 aggregation was assayed using Aβ1-42 ammonium hydroxide. Results: SE showed hormetic growth stimulation at lower concentrations in both neuron precursors and differentiated cells. SE reproducibly inhibited Aβ-induced cytotoxicity against both undifferentiated and differentiated neuron cells. Both the extent of differentiation induction and viability depended on the cell density, suggesting the release of growth and differentiation stimulation substances into culture supernatant. Higher concentrations of SE partially reduced the Aβ1-42 aggregation. Conclusion: Hormetic growth stimulation and inhibition of aggregation may be involved in the neuroprotective activity of SE.

  • Nerve cell
  • NGF
  • differentiation
  • amyloid β-peptide
  • protection
  • hormesis
  • bamboo leaf extract

We previously reported diverse biological activity of alkaline extract of the leaves of Sasa senanensis Rehder (SE), a group III over-the-counter drug (1). Among them, antiviral (2) and anti-UV activities (3) were prominent, possibly due to the presence of lignin carbohydrate complex in the extract (4, 5). We also manufactured a tooth paste that have anti-halitosis effects (6). Recently we found that SE alleviated the doxorubicin-induced cytotoxicity against primary human gingival epithelial cells (HGEP), by its growth promoting activity (7). However, it was not clear whether the SE's cell protective or growth promoting activities are a universal phenomenon or not, regardless of cell types.

Alzheimer's disease (AD) is the most common neurodegenerative disease and the leading cause of dementia in elderly people, and characterized by extracellular neuritic plaques made of aggregated forms of neurotoxic amyloid β-peptide (Aβ) and intracellular deposits of abnormally phosphorylated tau protein (8). In lipid rafts of cell membranes, amyloid precursor protein (APP) is enzymatically cleaved into Aβ peptides. Especially the 42-amino acid fragment (Aβ1-42) easily aggregates and self-assembles to form a heterogeneous mixture of oligomers and protofibrils, which ultimately deposit in senile plaques. Small soluble Aβ oligomers are considered as the major neurotoxic species in AD (9). Aβs have been reported to induce apoptosis in neuronal cells by mitochondrial dysfunction and oxidative stress (10), alteration of metal ion influx (11), endoplasmic reticulum stress (12) and impaired autophagy (13). In order to test the generality of cell protective activity of SE, we investigated here whether SE protects the neuronal cell death induced by amyloid β-peptides (Aβ1-42 and Aβ25-35).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Criteria for differentiated cells (A) and selectivity index (SI) for quantifying the protective effects for Aβ-toxicity.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Determination of optimal treatment time with Aβ peptides to express maximum toxicity. PC12 and SH-SY5Y cells were inoculated at 3 and 2 x104/cm2, and incubated to achieve complete cell attachment. Cells were treated for 4, 8, 12, 48, 72 or 96 h without (control) or with the indicated concentrations of Aβ1-42 (upper column) or Aβ25-35 (lower column), and then viable cell number was determined by MTT method, and expressed as % of control. Each value represents mean±S.D. (n=4).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Effect of preincubation of Aβ peptides on the cytotoxicity induction. Aβ1-42 and Aβ25-35 solution were preincubated at 37°C for 0 (control), 3 or 6 h. PC12 (upper column) and SH-SY5Y cells (lower column) were then exposed to the indicated concentrations of Aβ1-42 or Aβ25-35, and then viable cell number was determined by MTT method, and expressed as % of control. Each value represents mean±S.D. (n=4).

We have used two different assay systems using undifferentiated PC12 pheochromocytoma cells (14) and human SH-SY5Y neuroblastoma cells (15, 16), grown in DMEM medium supplemented with 10% FBS in two uncoated culture plates, and (ii) differentiating PC12 cells, induced by 50 ng/ml nerve growth factor (NGF) in DMEM supplemented with 1%FBS in five different 96-microwell plates (two uncoated, one poly-l-lysine coated, two collagen-coated plates).

Materials and Methods

Materials. The following chemicals and reagents were obtained from the indicated companies: Dulbecco's modified Eagle's medium (DMEM), human recombinant NGF, dimethyl sulfoxide (DMSO) (Wako Pure Chemical Ind., Ltd., Osaka, Japan); fetal bovine serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich Inc., St. Louis, MO, USA); Aβ1-42 and Aβ25-35 (Cosmo Bio Co., Ltd., Tokyo, Japan). NGF (dissolved in water at 0.5 mg/ml), Aβ1-42 (dissolved in DMSO at 1 mM) and Aβ25-35 (dissolved in water at 0.1 mg/m) were frozen at −20°C. The following 96-microwell plates were purchased from the indicated companies: TrueLine (Nippon Genetics Co., Ltd., Tokyo, Japan), TPP (Techno Plastic Products AG, Trasadingen, Swizeland), BioCoat™ Collagen I 96-well plate, BioCoat™ Collagen I 96-well plate, BioCoat™ Poly-l-Lysine 96-well plate (Corning Inc., Corning, Canton, NY, USA).

Cell culture. PC12, a cell line derived from a pheochromocytoma of the rat adrenal medulla (14), and SH-SY5Y, cloned from a human bone marrow biopsy derived line called SK-N-SH (15, 16) were purchased from Riken Cell Bank (Tsukuba, Japan). These cells were cultured in DMEM supplemented with 10% FBS, 100 units/ml, penicillin G and 100 μg/ml streptomycin under a humidified 5% CO2 atmosphere. The superiority of DMEM over mixed culture medium (DMEM+Ham12) has been reported in our previous paper (17).

Determination of viable cell number. The culture medium was removed, and replaced with fresh medium containing 0.2 mg/ml MTT in the presence (for differentiated cells) or absence (for non-differentiated cells) of 50 ng/ml NGF. The cells were incubated for 1 h, and the formazan precipitate was dissolved in DMSO to measure the absorbance at 560 nm with a plate leader (Infinite F 50 R, TECAN, Kawasaki, Japan).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Protective activity of SE and other antioxidants against the Aβ-induced cytotoxicity in PC12 (upper column) and SH-SY5Y cells (lower column). Cells were incubated for 24 h with the indicated concentrations of SE, EGCG or resveratrol in the presence of 400 nM Aβ1-42 or 1,600 nM Aβ25-35. Each value represents mean±S.D. (n=4).

Induction of differentiation toward neurons. For the induction of differentiation, PC12 cells were incubated for the indicated times with differentiating inducing medium (DMEM supplemented with 1%FBS, 50 ng/ml NGF and antibiotics). Differentiated cells were defined as the cells in which the extended neuritis exceeds the longest diameter of each cell, assessed under the light microscope (EVOSfl, ThermoFisher Scientific, Waltham, Mass, USA) (Figure 1A).

Neuroprotection assay. Undifferentiated (PC12, SH-SY5Y) and differentiated PC12 cells were treated with Aβ1-42 and Aβ25-35 for the 24~48 hours in the presence of increasing concentrations of test samples. The viable cell number was determined as described above. The 50% cytotoxic concentration (CC50) was determined from the amyloid peptide-free culture, and the 50% effective concentration (EC50) that reduced the amyloid peptide-induced cytotoxicity by 50% were calculated (Figure 1B). The protective effect was quantified by the selectivity index (SI), using the following formula: SI=CC50/EC50 (Figure 1B).

Detection of Aβ fibril formation. Aβ1-42 aggregation was measured using Aβ1-42 ammonium hydroxide (rPeptide, Georgia, USA). To measure the Aβ1-42 fibril formation in 96-well black microplates, 25 μl of 400 μM Thioflavin (ThT) and 10 μl of each concentration of SE were added into each well and then mixed with 23 μl of 221 μM Aβ solution. Final Aβ1-42 peptide concentration were ~50 μM, and final SE concentrations were 0.5, 0.1, 0,05 and 0.01%. ThT fluorescence signal was monitored at intervals of 10 min for 3 h at 37°C with an excitation wavelength (λex) of 440 nm and an emission wavelength (λem) of 485 nm, and 15 sec shaking between reads to facilitate aggregation using a SpectraMax i3 (Molecular Devices, Sunnyvale, CA, USA). This gave 6 readings for each well sample.

Statistical treatment. Experimental values are expressed as the mean±standard deviation (SD) of triplicate or quadruplicate samples. Statistical analysis was performed by using Student's t-test and Boferroni post hoc test. A p-value <0.05 was considered significant.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Comparison of cell growth on five different 96-microwell plates. PC12 cells were inoculated on four (Exp. I) or five different plates (Exp. II) at the indicated cell density, and incubated for 2 days to complete cell attachment. Cells were cultured for 2~8 days in fresh differentiation medium containing 50 ng/ml NGF and 1%FBS, and viable cell number was determined. Each value represents mean±S.D. (n=6).

Results

Optimal condition for cytotoxicity induction by amyloid peptides. We first investigated the optimal treatment time with amyloid β-peptides. When PC12 cells were incubated for 4, 8, 24, 48, 72 or 96 h with increasing concentrations of Aβ1-42 (A) and Aβ25-35 (B) (Figure 2), their cytotoxicity became maximum after 24 h. The optimal concentration of Aβ1-42 and Aβ25-35 was 0.08~2.1 and 0.1~12 μM, respectively. When SH-SY5Y cells were similarly incubated with Aβ1-42 (C) and Aβ25-35 (D) (Figure 2), strongest cytotoxicity emerged 24 h after treatment. The optimal concentration of Aβ1-42 and Aβ25-35 was 0.36~2.1 and 0.1~12 μM, respectively. Their viability declined to nearly half of the control, consistent with previous reports (18-21).

It has been generally accepted that the oligomerization of Aβ enhances its cytotoxicity (22). We investigated whether preincubation of amyloid peptides at 37°C, a condition that enhances oligomerization, may augment their cytotoxicity. In contrast to our expectation, cytotoxicity of both Aβ1-42 and Aβ25-35 did not change apparently without or with preincubation for 3 or 6 h. Comparable cytotoxicity was induced at the concentration range of 0.075~1.2 and 0.3~4.8 μM, respectively (upper panel) (Figure 3). Similar superimposable dose-response curves were observed regardless of preincubation in SH-SY5Y cells (lower panel) (Figure 3). Based on these experiments, we did not preincubate Aβ peptides for the following experiments. It is possible that Aβ gradually becomes aggregated during the 24-h incubation time, regardless of preincubation.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Effect of different types of plates on the incidence of nerve cell differentiation. PC12 cells were grown as in Exp. II of Figure 5, and approximately 100 cells on each well were checked for their morphology under light microscope to calculate the percent of differentiated cells, as described in Figure 1A.

SE protects PC12 and SH-SY5Y cells from Aβ-induced toxicity. For the quantification of neuroprotective activity, we have to first calculate the CC50 (for the cytotoxicity index) and EC50 (for the efficacy index). The selection index (SI), that reflects both cytotoxicity and efficacy, was calculated by the following equation: SI=CC50/EC50 (Figure 1B).

SE potently protected undifferentiated PC12 cells (SI=<1; 5.6) and SH-SY5Y cells (SI=37.2; >108) from Aβ1-42 and Aβ25-35-induced toxicity, respectively (Exp. I, Figure 4). This indicates that SE can be used as a positive control.

We next investigated various antioxidants for their ability to protect PC12 and SH-SY5Y cells from Aβ-induced toxicity (Exp. II, Figure 4). SE, used as a positive control, reproducibly showed potent neuroprotective activity [SI=7.1 (Aβ1-42), SI=5.0 (Aβ25-35) in PC12 cells; SI=141.1 (Aβ1-42), SI=<1 (Aβ25-35) in SH-SY5Y cells]. On the other hand, epigallocatechin gallate (EGCG), a main component of green tea, showed much weaker protective activity [SI=<1 (Aβ1-42), SI=<1 (Aβ25-35) in PC12; SI=6.1 (Aβ1-42), SI=<1 (Aβ25-35) in SH-SY5Y]. Resveratrol, a popular stilbenoid contained in wine, showed no protective effect (SI=<1) (right panel).

SE protects the differentiated neuron cells from Aβ-induced toxicity. We first established which types of 96-microwell plates are the best for maintaining the growth and differentiation in the differentiation medium (Figure 5). We used the following four different plates (TrueLine, TPP, poly-l-lysine coated, collagen type-I-coated) (Exp. 1) and five different plates (TrueLine, TPP, poly-l-lysine coated, collagen type-I-coated, collagen type-IV-coated) (Exp. II). When the inoculated cell density was set to below 0.13×104/cm2 in either cases, cell viability declined dramatically, due to the induction of apoptosis (characterized by cell shrinkage) (observed under light microscope, data not shown). This suggests that a certain number of cells are required to maintain the growth and nerve cell differentiation. Cells inoculated on collagen type-IV coated plates, were still attached, even at extremely higher cell density (Exp. I). Repeated experiments confirmed that both collagen type-I and -IV plates maintained the highest cell density at day 8, without cell detachment, whereas significant cell detachment was observed in poly-lysine-coated plate even at an earlier stage (day 4) (Exp. II, Figure 5).

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Protective effect of SE on Aβ-induced cytotoxicity in differentiating PC12 cells. PC12 cells were induced to differentiate with 50 nM NGF in differentiation medium, and then exposed to vehicle (control) or with 20 nM Aβ1-42 or 833 nM Aβ25-35 in the presence of increasing concentrations of SE. Viable cell number was then determined by MTT method, and expressed as % of control. Each value represents mean±S.D. (n=6).

The percent of differentiated cells was declined with decreasing inoculation number of cells (Figure 6). At the later stage (day 7 or day 8), cells attached on four plates other than poly-l-lysine-coated plates became fully differentiated (Figure 6).

When PC cells were treated for 7 days with 50 ng/ml NGF in collagen type-I-coated plates, they extended well neurites, characteristic to neurons (A) (Figure 7). Addition of 0.21 μM Aβ1-42 for the last 2 days (day 5~day 7) resulted in some interruption of neurite outgrowth (A) and reduction of cell viability to 69% of control (B). Addition of SE dose-dependently reversed the Aβ1-42-induced cell toxicity, yielding the SI value of 50 (B). Similarly, addition of 0.83 μM Aβ25-35 reduced the cell viability to 65% of control, and addition of SE dose-dependently reversed the Aβ25-35-induced cell toxicity, yielding the SI value of 75.3 (B). Cytotoxicity of higher concentration of SE was slightly inhibited by amyloid peptides, suggesting the interaction between these molecules.

Inhibition of Aβ1-42 aggregation by SE. SE at relatively higher concentrations (0.5~5%), but not lower concentrations (0.01~0.05%), significantly inhibited Aβ1-42 aggregation (p<0.05) (Figure 8).

Discussion

The present study demonstrated that SE inhibited the Aβ-induced toxicity against both undifferentiated PC12 and SH-SY5Y cells, and differentiated PC12 cells. We also found that lower concentrations (0.025~1.56%) of SE stimulated the growth of both PC12 and SH-SY5Y cells (Figure 4). Growth stimulation observed at lower doses of toxicans and radiations is known as hormesis (23). Maximum hermetic stimulation of growth was 32, 10 and 26% (mean=23%) in PC12 cells, and 40, 44 and 46% (mean=43%) in SH-SY5Y cells, respectively (Figure 4). EGCG, that also showed slightly lower protective effects, stimulated their growth by 6 and 23% (mean 15%). On the other hand, resveratrol, that showed no apparent protective activity, stimulated their growth only by 0~4% (Exp. II in Figure 4). These data suggest that the protective activity of SE may partially be due to its growth promoting activity. We have previously reported that SE also stimulated the growth of HGEP (7). It remained to be investigated whether hormetic response by SE is a universal phenomenon, or observed only in cells that express some specific receptors. Since the inhibition of Aβ1-42 aggregation was found only above 0.5% of SE, the action point of SE might not be Aβ1-42 aggregation.

Many antioxidants including resveratrol have been reported to inhibit the cytotoxicity of Aβ peptides (24-26). These findings are contradictory to our negative results of resveratrol (Figure 4). This discrepancy may be due to the difference in culturing conditions, or the quantitation methods. Most of the previous studies have used undifferentiated PC12 cells that have not extended neurites. We are now re-evaluating their neuroprotective activity using fully differentiated PC12 cells.

The present study also demonstrated that cells, inoculated at extremely low density, stopped their growth and differentiation (Figures 5 and 6), even if supplied by enough amounts of NGF. This suggests that neurite growth and maturation need the presence of a high density of differentiating cells, that may be a source of growth and differentiation stimulators other than NGF.

Since it is unlikely that higher-molecular weight substances present in SE pass through the blood brain barrier, fractionation and investigation of protective activity of lower molecular components present in SE are underway.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Dose-dependent inhibition of Aβ1-42 aggregation. Aβ1-42 aggregation was measured every 10 min at 37°C using Thioflavin, at Excitation 440 nm, Emission 485nm. Each value represents mean±S.D. (n=6). We found significant reduction of Aβ1-42 aggregation by 0.5% SE (0~150 min) (p<0.005).

Acknowledgements

This work was partially supported by KAKENHI from the Japan Society for the Promotion of Science (JSPS) (16K11519).

Footnotes

  • This article is freely accessible online.

  • Conflicts of Interest

    The first Author (HS) was supported by Daiwa Biological Research Institute Co., Ltd., Kanagawa, Japan. The Authors wish to confirm that such financial support has not influenced the outcome or the experimental data.

  • Received November 29, 2017.
  • Revision received December 15, 2017.
  • Accepted December 18, 2017.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Sakagami H
    1. Sakagami H,
    2. Matsuta T,
    3. Yasui T,
    4. Oguchi K,
    5. Kitajima M,
    6. Sugiura T,
    7. Oizumi H,
    8. Oizumi T
    : Chapter 8: Functional evaluation of Sasa Makino et Shibata leaf extract as group III OTC drug. In: Alternative Medicine. Sakagami H (eds.), pp. 171-200, 2012.
  2. ↵
    1. Sakagami H,
    2. Fukuchi K,
    3. Kanamoto T,
    4. Terakubo S,
    5. Nakashima H,
    6. Natori T,
    7. Suguro-Kitajima M,
    8. Oizumi H,
    9. Yasui T,
    10. Oizumi T
    : Synergism of alkaline extract of the leaves of Sasa senanensis Rehder and antiviral agents. In Vivo 30(4): 421-426, 2016.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Sakagami H,
    2. Sheng H,
    3. Okudaira N,
    4. Yasui T,
    5. Wakabayashi H,
    6. Jia J,
    7. Natori T,
    8. Suguro-Kitajima M,
    9. Oizumi H,
    10. Oizumi T
    : Prominent anti-UV activity and possible cosmetic potential of lignin-carbohydrate complex. Review. In Vivo 30(4): 331-339, 2016.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Sakagami H,
    2. Kushida T,
    3. Oizumi T,
    4. Nakashima H,
    5. Makino T
    : aDistribution of lignin carbohydrate complex in plant kingdom and its functionality as alternative medicine. Pharmacol Ther 128: 91-105, 2010.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sakagami H,
    2. Sheng H,
    3. Ono K,
    4. Komine Y,
    5. Miyadai T,
    6. Terada Y,
    7. Nakada D,
    8. Tanaka S,
    9. Matsumoto M,
    10. Yasui T,
    11. Watanabe K,
    12. Jin J,
    13. Natori T,
    14. Suguro-Kitajima M,
    15. Oizumi H,
    16. Oizumi T
    : Anti-halitosis effect of toothpaste supplemented with alkaline extract of the leaves of Sasa senanensis Rehder. In Vivo 30(2): 107-111, 2016.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Grumezescu
    1. Sakagami H,
    2. Sheng H,
    3. Yasui T,
    4. Fukuchi K,
    5. Oizumi T,
    6. Ohno H,
    7. Yamamoto M,
    8. Fukuda T,
    9. Kotohda K,
    10. Yoshida H,
    11. Kanamoto Terakubo S,
    12. Nakashima H
    : Chapter 18. Therapeutic potential of solubilized nanolignin against oral diseases. In: Nanostructures for Oral Medicicne, Grumezescu (ed.), Elsevier, Amsterdam, Netherlands, pp. 545-576, 2017.
  7. ↵
    1. Sakagami H,
    2. Okudaira N,
    3. Masuda Y,
    4. Amano O,
    5. Yokose S,
    6. Kanda Y,
    7. Suguro M,
    8. Natori T,
    9. Oizumi H,
    10. Oizumi T
    : Induction of apoptosis in human oral keratinocyte by doxorubicin. Anticancer Res 37(3): 1023-1029, 2017.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Jouanne M,
    2. Rault S,
    3. Voisin-Chiret AS
    : Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents. Eur J Med Chem 139: 153-167, 2017.
    OpenUrl
  9. ↵
    1. Nizynski B,
    2. Dzwolak W,
    3. Nieznanski K
    : Amyloidogenesis of Tau protein. Protein Sci 26(11): 2126-2150, 2017.
    OpenUrl
  10. ↵
    1. Jazvinšćak Jembrek M,
    2. Hof PR,
    3. Šimić G
    : Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation. Oxid Med Cell Longev 2015: 346783, 2015.
    OpenUrl
  11. ↵
    1. Wang P,
    2. Wang ZY
    : Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease. Ageing Res Rev 35: 265-290, 2017.
    OpenUrl
  12. ↵
    1. Gerakis Y,
    2. Hetz C
    : Emerging roles of ER stress in the aetiology and pathogenesis of Alzheimer's disease. FEBS J, 2017. [epub ahead of print]
  13. ↵
    1. Salminen A,
    2. Kaarniranta K,
    3. Kauppinen A,
    4. Ojala J,
    5. Haapasalo A,
    6. Soininen,
    7. Hiltunen M
    : Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Prog Neurobiol J 106-107: 33-54, 2013.
    OpenUrl
  14. ↵
    1. Greene LA,
    2. Tischler AS
    : Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73(7): 2424–2428, 1976.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Biedler JL,
    2. Helson L,
    3. Spengler BA
    : Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652, 1973.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Biedler JL,
    2. Roffler-Tarlov S,
    3. Schachner M,
    4. Freedman LS
    : Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757, 1978.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Sakagami H,
    2. Suzuki R,
    3. Shirataki Y,
    4. Iwama S,
    5. Nakagawa M,
    6. Suzuki H,
    7. Tanaka K,
    8. Tamura N,
    9. Takeshima H
    : Re-evaluation of culture condition of PC12 and SH-SY5Y cells based on growth rate and amino acid consumption. In Vivo 31(11): 1089-1095, 2017.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Ma R,
    2. Hu J,
    3. Huang C,
    4. Wang M,
    5. Xiang J,
    6. Li G
    : JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35. Br J Pharmacol 171(13): 3234-3245, 2014.
    OpenUrl
    1. Ai Z,
    2. Li C,
    3. Li L,
    4. He G
    : Resveratrol inhibits β-amyloid-induced neuronal apoptosis via regulation of p53 acetylation in PC12 cells. Mol Med Rep 11: 2429-2434, 2015.
    OpenUrl
    1. Zhang Y,
    2. Jiao G,
    3. Song C,
    4. Gu S,
    5. Brown RE,
    6. Zhang J,
    7. Zhang P,
    8. Gagnon J,
    9. Locke S,
    10. Stefanova R,
    11. Pelletier C,
    12. Zhang Y,
    13. Lu H
    : An extract from shrimp processing by-products protects SH-SY5Y cells from neurotoxicity induced by Aβ25-35. Mar Drugs 15(3): 83, 2017.
    OpenUrl
  19. ↵
    1. Chilumuri A,
    2. Milton NG
    : The role of neurotransmitters in protection against amyloid- β toxicity by KiSS-1 overexpression in SH-SY5Y neurons. ISRN Neurosci 2013: 253210, 2013.
    OpenUrl
  20. ↵
    1. Rivera I,
    2. Capone R,
    3. Cauvi DM,
    4. Arispe N,
    5. De Maio A
    : Modulation of Alzheimer's amyloid β peptide oligomerization and toxicity by extracellular Hsp70. Cell Stress Chaperones, 2017. [epub ahead of print]
  21. ↵
    1. Calabrese EJ
    : Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features. Environ Pollut 182: 452-460, 2013.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Gurer-Orhan H,
    2. Karaaslan C,
    3. Ozcan S,
    4. Firuzi O,
    5. Tavakkoli M,
    6. Saso L,
    7. Suzen S
    : Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage. Bioorg Med Chem 24(8): 1658-1664, 2016.
    OpenUrl
    1. Guimarães CC,
    2. Oliveira DD,
    3. Valdevite M,
    4. Saltoratto AL,
    5. Pereira SI,
    6. França Sde C,
    7. Pereira AM,
    8. Pereira PS
    : The glycosylated flavonoids vitexin, isovitexin, and quercetrin isolated from Serjania erecta Radlk (Sapindaceae) leaves protect PC12 cells against amyloid-β25-35 peptide-induced toxicity. Food Chem Toxicol 86: 88-94, 2015.
    OpenUrl
  23. ↵
    1. Ai Z,
    2. Li C,
    3. Li L,
    4. He G
    : Resveratrol inhibits β-amyloid-induced neuronal apoptosis via regulation of p53 acetylation in PC12 cells. Mol Med Rep 11(4): 2429-2434, 2015.
    OpenUrl
PreviousNext
Back to top

In this issue

In Vivo
Vol. 32, Issue 2
March-April 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Protection of Differentiating Neuronal Cells from Amyloid β Peptide-induced Injury by Alkaline Extract of Leaves of Sasa senanensis Rehder
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Protection of Differentiating Neuronal Cells from Amyloid β Peptide-induced Injury by Alkaline Extract of Leaves of Sasa senanensis Rehder
HIROSHI SAKAGAMI, MAYUMI TSUJI, MINEKO TOMOMURA, YOSHIKO MASUDA, SOICHI IWAMA, MIKA NAKAGAWA, HAYATO SUZUKI, KENTA TANAKA, TOMOYUKI ABE, NOBUAKI TAMURA, AKITO TOMOMURA, SATOSHI YOKOSE, HIROSHI TAKESHIMA, TAKENORI NATORI, MISAKI HORIUCHI, TOMOHIRO FUJISAWA, YUJI KIUCHI, KATSUJI OGUCHI, TOSHIKAZU YASUI, HIROSHI OIZUMI, TAKAAKI OIZUMI
In Vivo Mar 2018, 32 (2) 231-239;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Protection of Differentiating Neuronal Cells from Amyloid β Peptide-induced Injury by Alkaline Extract of Leaves of Sasa senanensis Rehder
HIROSHI SAKAGAMI, MAYUMI TSUJI, MINEKO TOMOMURA, YOSHIKO MASUDA, SOICHI IWAMA, MIKA NAKAGAWA, HAYATO SUZUKI, KENTA TANAKA, TOMOYUKI ABE, NOBUAKI TAMURA, AKITO TOMOMURA, SATOSHI YOKOSE, HIROSHI TAKESHIMA, TAKENORI NATORI, MISAKI HORIUCHI, TOMOHIRO FUJISAWA, YUJI KIUCHI, KATSUJI OGUCHI, TOSHIKAZU YASUI, HIROSHI OIZUMI, TAKAAKI OIZUMI
In Vivo Mar 2018, 32 (2) 231-239;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Prominent Anti-UVC Activity of Lignin Degradation Products
  • Effects of Kumaizasa (Sasa senanensis) Leaf Extract on Innate Immune Regulation in HEK293 Cells and Macrophages
  • Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and Drosophila melanogaster model of Alzheimers disease
  • Augmentation of Neurotoxicity of Anticancer Drugs by X-Ray Irradiation
  • Partial Protection of Paclitaxel-induced Neurotoxicity by Antioxidants
  • Change in Anticancer Drug Sensitivity During Neuronal Differentiation of PC12 Cells
  • Google Scholar

More in this TOC Section

  • Over-expression of Truncated IK Ameliorates Dinitrochlorobenzene-Induced Allergic Contact Dermatitis Lesions in BALB/c Mice
  • Association of Matrix Metalloproteinase-7 Genotypes With Nasopharyngeal Carcinoma Risk
  • Age- and Periodontal Disease Independent Correlation of Salivary Amino Acids
Show more Experimental Studies

Similar Articles

Keywords

  • Nerve cell
  • NGF
  • differentiation
  • amyloid β-peptide
  • protection
  • hormesis
  • bamboo leaf extract
In Vivo

© 2025 In Vivo

Powered by HighWire